UnitedHealth Group (NYSE:UNH) Given New $400.00 Price Target at Oppenheimer

UnitedHealth Group (NYSE:UNH - Get Free Report) had its target price dropped by equities research analysts at Oppenheimer from $600.00 to $400.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an "outperform" rating on the healthcare conglomerate's stock. Oppenheimer's price objective indicates a potential upside of 27.66% from the company's previous close.

Several other research firms have also commented on UNH. Robert W. Baird dropped their target price on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a report on Wednesday. HSBC reiterated a "hold" rating and issued a $490.00 price target on shares of UnitedHealth Group in a research note on Tuesday, April 22nd. KeyCorp lowered their target price on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a report on Wednesday. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price target for the company from $560.00 to $350.00 in a research report on Wednesday. Finally, Truist Financial reduced their target price on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a report on Monday, April 21st. Six equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $536.05.

UnitedHealth Group Trading Up 0.6%

UNH stock traded up $1.96 during mid-day trading on Wednesday, hitting $313.34. 14,262,570 shares of the company were exchanged, compared to its average volume of 5,010,923. The business has a fifty day simple moving average of $482.53 and a 200-day simple moving average of $519.28. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 12-month low of $309.10 and a 12-month high of $630.73. The firm has a market capitalization of $284.24 billion, a P/E ratio of 20.26, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm posted $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Hedge Funds Weigh In On UnitedHealth Group

Large investors have recently made changes to their positions in the stock. GDS Wealth Management lifted its position in shares of UnitedHealth Group by 9.4% during the 1st quarter. GDS Wealth Management now owns 25,325 shares of the healthcare conglomerate's stock valued at $13,264,000 after acquiring an additional 2,181 shares during the period. Capital Analysts LLC grew its stake in UnitedHealth Group by 3.4% in the 1st quarter. Capital Analysts LLC now owns 11,427 shares of the healthcare conglomerate's stock valued at $5,986,000 after acquiring an additional 381 shares during the last quarter. Humankind Investments LLC raised its position in UnitedHealth Group by 29.1% during the first quarter. Humankind Investments LLC now owns 3,265 shares of the healthcare conglomerate's stock worth $1,710,000 after acquiring an additional 736 shares during the last quarter. Vertex Planning Partners LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $234,000. Finally, Banco Bilbao Vizcaya Argentaria S.A. lifted its position in shares of UnitedHealth Group by 18.2% in the first quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 63,606 shares of the healthcare conglomerate's stock valued at $33,331,000 after acquiring an additional 9,774 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.